Wilmington Funds Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Wilmington Funds Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$33K	Buy	+2,529	New	+$31.9K	﹤0.01%	739

Other funds holding CDMO

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Wilmington Funds Management's CDMO Position: Q2 2014 in Review

Wilmington Funds Management opened a new position in Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2014: 2,529 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #739 among its holdings.

85 funds tracked by Wall St. Rank hold CDMO as of Q2 2014.

Wilmington Funds Management held 2,529 shares of Avid Bioservices, Inc. Common Stock worth $33K as of Q2 2014.
Avid Bioservices, Inc. Common Stock was a new Wilmington Funds Management position in Q2 2014.
Avid Bioservices, Inc. Common Stock made up ﹤0.01% of Wilmington Funds Management's portfolio in Q2 2014, its #739 holding.
85 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.